This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rowe, D. T.
Right arrow Articles by Green, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rowe, D. T.
Right arrow Articles by Green, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 06 1997, 1612-1615, Vol 35, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders

DT Rowe, L Qu, J Reyes, N Jabbour, E Yunis, P Putnam, S Todo and M Green
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, The Childrens Hospital of Pittsburgh, Pennsylvania 15261, USA.

A quantitative competitive PCR (QC-PCR) assay for Epstein-Barr virus (EBV) has been developed to provide accurate measurement of EBV genome load in pediatric transplant recipients at risk for developing posttransplant lymphoproliferative disorder (PTLD). The assay quantifies between 8 and 5,000 copies of the EBV genome in 10(5) lymphocytes after a 30-cycle amplification reaction. For 14 pediatric patients diagnosed with PTLD, the median EBV genome load was 4,000, and 13 of the 14 patients had values of >500 copies per 10(5) lymphocytes. Only 3 of 12 control transplant recipients not diagnosed with PTLD had detectable viral genome loads (median value, 40). This median was calculated by using the highest value obtained by PCR testing on each of these patients posttransplantation. PCR values of >500 copies per 10(5) lymphocytes appear to correlate with a diagnosis of PTLD. By a modified protocol, the EBV genome copy number in latently infected adults was estimated to be <0.1 copy per 10(5) lymphocytes.


This article has been cited by other articles:

  • Sokol, H, Beaugerie, L (2009). Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle. Gut 58: 1427-1436 [Abstract] [Full Text]  
  • Gorman, G. S., Tubridy, N. J., Hutchinson, M. (2009). Clinical Reasoning: An unusual case of papilledema after orthotopic liver transplantation. Neurology 73: e25-e29 [Full Text]  
  • Borhani, A. A., Hosseinzadeh, K., Almusa, O., Furlan, A., Nalesnik, M. (2009). Imaging of Posttransplantation Lymphoproliferative Disorder after Solid Organ Transplantation1. RadioGraphics 29: 981-1000 [Abstract] [Full Text]  
  • Fishman, J. A. (2007). Infection in Solid-Organ Transplant Recipients. NEJM 357: 2601-2614 [Full Text]  
  • Hakim, H., Gibson, C., Pan, J., Srivastava, K., Gu, Z., Bankowski, M. J., Hayden, R. T. (2007). Comparison of Various Blood Compartments and Reporting Units for the Detection and Quantification of Epstein-Barr Virus in Peripheral Blood. J. Clin. Microbiol. 45: 2151-2155 [Abstract] [Full Text]  
  • Martro, E., Ausina, V. (2005). The role of Epstein-Barr virus in pleural effusions of unknown aetiology: an interesting clinical perspective. Eur Respir J 26: 566-568 [Full Text]  
  • Stevens, S. J. C., Verkuijlen, S. A. W. M., Hariwiyanto, B., Harijadi, , Fachiroh, J., Paramita, D. K., Tan, I. B., Haryana, S. M., Middeldorp, J. M. (2005). Diagnostic Value of Measuring Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral mRNA in Relation to Anti-EBV Immunoglobulin A (IgA) and IgG Antibody Levels in Blood of Nasopharyngeal Carcinoma Patients from Indonesia. J. Clin. Microbiol. 43: 3066-3073 [Abstract] [Full Text]  
  • Schauer, E., Webber, S., Green, M., Rowe, D. (2004). Surface Immunoglobulin-Deficient Epstein-Barr Virus-Infected B Cells in the Peripheral Blood of Pediatric Solid-Organ Transplant Recipients. J. Clin. Microbiol. 42: 5802-5810 [Abstract] [Full Text]  
  • Martro, E., Cannon, M. J., Dollard, S. C., Spira, T. J., Laney, A. S., Ou, C.-Y., Pellett, P. E. (2004). Evidence for both Lytic Replication and Tightly Regulated Human Herpesvirus 8 Latency in Circulating Mononuclear Cells, with Virus Loads Frequently below Common Thresholds of Detection. J. Virol. 78: 11707-11714 [Abstract] [Full Text]  
  • Piriou, E. R., van Dort, K., Nanlohy, N. M., Miedema, F., van Oers, M. H., van Baarle, D. (2004). Altered EBV Viral Load Setpoint after HIV Seroconversion Is in Accordance with Lack of Predictive Value of EBV Load for the Occurrence of AIDS-Related Non-Hodgkin Lymphoma. J. Immunol. 172: 6931-6937 [Abstract] [Full Text]  
  • Wadowsky, R. M., Laus, S., Green, M., Webber, S. A., Rowe, D. (2003). Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR. J. Clin. Microbiol. 41: 5245-5249 [Abstract] [Full Text]  
  • Andreone, P., Gramenzi, A., Lorenzini, S., Biselli, M., Cursaro, C., Pileri, S., Bernardi, M. (2003). Posttransplantation Lymphoproliferative Disorders. Arch Intern Med 163: 1997-2004 [Abstract] [Full Text]  
  • Calabrese, L. H., Albrecht, M., Young, J., McCarthy, P., Haug, M., Jarcho, J., Zackin, R. (2003). Successful Cardiac Transplantation in an HIV-1-Infected Patient with Advanced Disease. NEJM 348: 2323-2328 [Full Text]  
  • Straathof, K. C.M., Bollard, C. M., Rooney, C. M., Heslop, H. E. (2003). Immunotherapy for Epstein-Barr Virus-Associated Cancers in Children. The Oncologist 8: 83-98 [Abstract] [Full Text]  
  • Jenkins, F. J., Rowe, D. T., Rinaldo, C. R. Jr. (2003). Herpesvirus Infections in Organ Transplant Recipients. CVI 10: 1-7 [Full Text]  
  • Stevens, S. J. C., Verkuijlen, S. A. W. M., Brule, A. J. C. v. d., Middeldorp, J. M. (2002). Comparison of Quantitative Competitive PCR with LightCycler-Based PCR for Measuring Epstein-Barr Virus DNA Load in Clinical Specimens. J. Clin. Microbiol. 40: 3986-3992 [Abstract] [Full Text]  
  • Rose, C., Green, M., Webber, S., Kingsley, L., Day, R., Watkins, S., Reyes, J., Rowe, D. (2002). Detection of Epstein-Barr Virus Genomes in Peripheral Blood B Cells from Solid-Organ Transplant Recipients by Fluorescence In Situ Hybridization. J. Clin. Microbiol. 40: 2533-2544 [Abstract] [Full Text]  
  • Gartner, B. C., Schafer, H., Marggraff, K., Eisele, G., Schafer, M., Roemer, K., Laws, H.-J., Sester, M., Sester, U., Einsele, H., Mueller-Lantzsch, N. (2002). Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative Disease. J. Clin. Microbiol. 40: 351-358 [Abstract] [Full Text]  
  • van Esser, J. W. J., van der Holt, B., Meijer, E., Niesters, H. G. M., Trenschel, R., Thijsen, S. F. T., van Loon, A. M., Frassoni, F., Bacigalupo, A., Schaefer, U. W., Osterhaus, A. D. M. E., Gratama, J. W., Lowenberg, B., Verdonck, L. F., Cornelissen, J. J. (2001). Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98: 972-978 [Abstract] [Full Text]  
  • Meru, N, Davison, S, Whitehead, L, Jung, A, Mutimer, D, Rooney, N, Kelly, D, Niedobitek, G (2001). Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens. Mol. Pathol. 54: 264-269 [Abstract] [Full Text]  
  • Lin, J.-C., Chen, K. Y., Wang, W.-Y., Jan, J.-S., Liang, W.-M., Tsai, C.-S., Wei, Y.-H. (2001). Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and Survival. JCO 19: 2607-2615 [Abstract] [Full Text]  
  • Stevens, S. J. C., Pronk, I., Middeldorp, J. M. (2001). Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen. J. Clin. Microbiol. 39: 1211-1216 [Abstract] [Full Text]  
  • Rose, C., Green, M., Webber, S., Ellis, D., Reyes, J., Rowe, D. (2001). Pediatric Solid-Organ Transplant Recipients Carry Chronic Loads of Epstein-Barr Virus Exclusively in the Immunoglobulin D-Negative B-Cell Compartment. J. Clin. Microbiol. 39: 1407-1415 [Abstract] [Full Text]  
  • Stevens, S. J. C., Verschuuren, E. A. M., Pronk, I., van der Bij, W., Harmsen, M. C., The, T. H., Meijer, C. J. L. M., van den Brule, A. J. C., Middeldorp, J. M. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97: 1165-1171 [Abstract] [Full Text]  
  • Jabs, W. J., Hennig, H., Kittel, M., Pethig, K., Smets, F., Bucsky, P., Kirchner, H., Wagner, H. J. (2001). Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders. J. Clin. Microbiol. 39: 564-569 [Abstract] [Full Text]  
  • Yang, J., Tao, Q., Flinn, I. W., Murray, P. G., Post, L. E., Ma, H., Piantadosi, S., Caligiuri, M. A., Ambinder, R. F. (2000). Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 96: 4055-4063 [Abstract] [Full Text]  
  • Bai, X., Rogers, B. B., Harkins, P. C., Sommerauer, J., Squires, R., Rotondo, K., Quan, A., Dawson, D. B., Scheuermann, R. H. (2000). Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients. J. Mol. Diagn. 2: 191-201 [Abstract] [Full Text]  
  • KASISKE, B. L., VAZQUEZ, M. A., HARMON, W. E., BROWN, R. S., DANOVITCH, G. M., GASTON, R. S., ROTH, D., SCANDLING, J. D. JR., SINGER, G. G. (2000). Recommendations for the Outpatient Surveillance of Renal Transplant Recipients. J. Am. Soc. Nephrol. 11 : S1-S86 [Abstract] [Full Text]  
  • Hopwood, P., Crawford, D. H (2000). The role of EBV in post-transplant malignancies: a review. J. Clin. Pathol. 53: 248-254 [Full Text]  
  • Baldanti, F., Grossi, P., Furione, M., Simoncini, L., Sarasini, A., Comoli, P., Maccario, R., Fiocchi, R., Gerna, G. (2000). High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders. J. Clin. Microbiol. 38: 613-619 [Abstract] [Full Text]  
  • Niesters, H. G. M., van Esser, J., Fries, E., Wolthers, K. C., Cornelissen, J., Osterhaus, A. D. M. E. (2000). Development of a Real-Time Quantitative Assay for Detection of Epstein-Barr Virus. J. Clin. Microbiol. 38: 712-715 [Abstract] [Full Text]  
  • Stevens, S. J. C., Vervoort, M. B. H. J., van den Brule, A. J. C., Meenhorst, P. L., Meijer, C. J. L. M., Middeldorp, J. M. (1999). Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR. J. Clin. Microbiol. 37: 2852-2857 [Abstract] [Full Text]  
  • Limaye, A. P., Huang, M.-L., Atienza, E. E., Ferrenberg, J. M., Corey, L. (1999). Detection of Epstein-Barr Virus DNA in Sera from Transplant Recipients with Lymphoproliferative Disorders. J. Clin. Microbiol. 37: 1113-1116 [Abstract] [Full Text]  
  • Kimura, H., Morita, M., Yabuta, Y., Kuzushima, K., Kato, K., Kojima, S., Matsuyama, T., Morishima, T. (1999). Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay. J. Clin. Microbiol. 37: 132-136 [Abstract] [Full Text]  
  • Pepperl, S., Benninger-Doring, G., Modrow, S., Wolf, H., Jilg, W. (1998). Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes. J. Virol. 72: 8644-8649 [Abstract] [Full Text]